Wolverine (BPC-157 / TB-500)
Researched combination of BPC-157 and TB-500 for VEGFR2 signalling and actin dynamics studies
24,57 €
Seleccionar opción
1
Analizado por HPLC — COA disponible para cada lote
Envío el mismo día antes de las 14:00 (hora UK)
Embalaje discreto · Protección de entrega disponible
A researched combination of two bioactive peptides: BPC-157 (a 15-amino acid partial sequence of gastric BPC protein) and TB-500 (a synthetic analogue of the Tβ4 actin-sequestering domain). Investigated in preclinical models for combined effects on VEGFR2-mediated angiogenesis and actin polymerisation dynamics. Used as a research tool in growth factor receptor and cytoskeletal biology studies.
Propiedades
| Appearance | White powder |
|---|---|
| Cas Number | N/A (Blend) |
| Form | Lyophilized powder |
| Heavy Metals | None Detected |
| Molecular Formula | N/A (Blend) |
| Molecular Weight | N/A (Blend) |
| Purity | ≥99% (HPLC) |
| Solubility | Refer to individual component solubility data. |
| Storage | Store in a dry environment away from direct sunlight. |
Certificado de análisis por componente
GLOW Batch #WLV-2501Cad. 2026-12-04
| Lote | Péptido | Fecha de caducidad | Certificado de análisis |
|---|---|---|---|
| WLV-2501B | TB-500 | 2026-12-04 | |
| WLV-2501A | BPC-157 | 2026-12-04 |
Opiniones de clientes
Aún no hay opiniones. ¡Sé el primero en opinar sobre este producto!
Preguntas frecuentes
The Wolverine bundle combines BPC-157 and TB-500, two peptides extensively studied for tissue repair and regeneration. The name references the character known for rapid healing, reflecting the synergistic research focus of this combination on accelerated tissue recovery models.